Tag: biotechnology

February 24, 2026

Hims & Hers Earnings: GLP-1 Scrutiny & Weight Loss Future

February 23, 2026

Gilead to Acquire Arcellx for $7.8B in Cancer Therapy Deal

February 20, 2026

Grail Cancer Test Fails, FDA Shifts Focus: Biotech News Roundup

February 20, 2026

Pharma & Biotech Moves: CDR-Life Names New CMO | STAT News

February 20, 2026

Grail Cancer Blood Test Fails Key NHS Trial, Shares Plummet

February 19, 2026

Grail Cancer Blood Test Fails Key NHS Trial | STAT News

February 18, 2026

RFK Jr.’s Health Team Divided on Pharma & Vaccine Policy at PhRMA Forum

February 17, 2026

Ocular Therapeutix’s Axpaxli Shows Promise in Macular Degeneration Trial | STAT News

February 15, 2026

FDA Rejects Moderna Flu Vaccine: Biotech Braces for Regulatory Shift

February 14, 2026

Pharma & Biotech Moves: Lexeo Therapeutics Hires New CMO | STAT News

February 13, 2026

FDA Rejects Disc Medicine’s Porphyria Drug Bitopertin in First Test of Makary Fast-Track Program

February 12, 2026

FDA Official Blocked Moderna Flu Vaccine Review: STAT Exclusive

February 11, 2026

Rare Disease Trials: Why Access to Hope Remains Limited for Many Families

February 9, 2026

FDA Rejects Regenxbio’s Gene Therapy for Hunter Syndrome

February 8, 2026

Moscow Bio-Drones: Pigeon Brain Chips for Remote Control

February 6, 2026

Biotech IPOs Return: 5 Companies Raise Nearly $1 Billion in a Week